{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:12:33Z","timestamp":1761513153299},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.radonc.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T04:15:31Z","timestamp":1340424931000},"page":"39-44","source":"Crossref","is-referenced-by-count":22,"title":["Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab \u2013 Pooled results from two prospective clinical trials"],"prefix":"10.1016","volume":"104","author":[{"given":"Andreas","family":"Hallqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2012.05.006_b0005","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0360-3016(01)01604-2","article-title":"Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group","volume":"50","author":"Auchter","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.05.006_b0010","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2001.19.8.2123","article-title":"Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer","volume":"19","author":"Langendijk","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.radonc.2009.02.010","article-title":"High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL","volume":"91","author":"Pijls-Johannesma","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.lungcan.2008.10.021","article-title":"How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group","volume":"65","author":"Nyman","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2012.05.006_b0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.lungcan.2010.05.011","article-title":"Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite \u2013 a phase II study from the Swedish Lung Cancer Study Group","volume":"71","author":"Hallqvist","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2012.05.006_b0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2012.05.006_b0035","doi-asserted-by":"crossref","unstructured":"Bjordal K, De Graeff A, Fayers PM, et al. on behalf of the EORTC Quality of Life Group. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head & neck patients. Eur J Cancer 2000;36:1796\u2013807.","DOI":"10.1016\/S0959-8049(00)00186-6"},{"key":"10.1016\/j.radonc.2012.05.006_b0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","article-title":"QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life","volume":"30A","author":"Bergman","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2012.05.006_b0045","unstructured":"EORTC Group for Research into Quality of Life. Bibliography. http:\/\/www.groups.eortc.be\/qol\/documentation_bibliography.htm; 2012 [accessed 16.04.12]."},{"key":"10.1016\/j.radonc.2012.05.006_b0050","unstructured":"Fayers P, Aaronson NK, Bjordal K, Curran D, Groenvold M. on behalf of the EORTC Quality of Life Study Group. EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: EORTC Quality of Life Group; 2001."},{"key":"10.1016\/j.radonc.2012.05.006_b0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1378\/chest.113.2.467","article-title":"Quality of life in patients with lung cancer: a review of literature from 1970 to 1995","volume":"113","author":"Montazeri","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2012.05.006_b0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4065\/79.8.1024","article-title":"Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis","volume":"79","author":"Svobodnik","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.radonc.2012.05.006_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1022232624891","article-title":"How quality of life data contribute to our understanding of cancer patients\u2019 experiences? A study of patients with lung cancer","volume":"12","author":"Montazeri","year":"2003","journal-title":"Qual Life Res"},{"key":"10.1016\/j.radonc.2012.05.006_b0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/02841869109088248","article-title":"Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures","volume":"30","author":"Bergman","year":"1991","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0075","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0360-3016(00)00439-9","article-title":"Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer","volume":"47","author":"Schaafsma","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.05.006_b0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1200\/JCO.2004.06.123","article-title":"Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial","volume":"22","author":"Sundstrom","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-8140(97)00188-6","article-title":"Age has no impact on acute and late toxicity of curative thoracic radiotherapy","volume":"46","author":"Pignon","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0090","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0169-5002(00)00179-3","article-title":"Quality of life in lung cancer patients: as an important prognostic factor","volume":"31","author":"Montazeri","year":"2001","journal-title":"Lung cancer"},{"key":"10.1016\/j.radonc.2012.05.006_b0100","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1200\/JCO.2005.02.527","volume":"23","author":"Maione","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(00)00158-4","article-title":"The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy","volume":"55","author":"Langendijk","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.05.006_b0110","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1200\/JCO.2009.23.7420","article-title":"Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801","volume":"27","author":"Movsas","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814012002484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814012002484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T15:53:03Z","timestamp":1542901983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814012002484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0167814012002484"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2012.05.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}